Renaissance Technologies's LMAT Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 180,502 shares of LeMaitre Vascular, Inc. (LMAT) worth $14.64 M, representing 0.02% of the portfolio. First purchased in 2014-Q1, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Renaissance Technologies has maintained a long-term strategic position in LMAT, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2017, adding 131,300 shares. Largest reduction occurred in Q4 2017, reducing 95,600 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's LeMaitre Vascular (LMAT) Holding Value Over Time
Track share changes against reported price movement
Quarterly LeMaitre Vascular (LMAT) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -100 | Reduce 0.06% | 180,502 | $81.10 |
| Q3 2025 | +21,902 | Add 13.80% | 180,602 | $87.51 |
| Q2 2025 | +4,400 | Add 2.85% | 158,700 | $83.05 |
| Q1 2025 | -9,500 | Reduce 5.80% | 154,300 | $83.90 |
| Q4 2024 | +1,300 | Add 0.80% | 163,800 | $92.14 |
| Q3 2024 | +22,400 | Add 15.99% | 162,500 | $92.89 |
| Q2 2024 | +4,164 | Add 3.06% | 140,100 | $82.28 |
| Q1 2024 | +21,936 | Add 19.24% | 135,936 | $66.36 |
| Q4 2023 | +22,200 | Add 24.18% | 114,000 | $56.76 |
| Q3 2023 | +16,100 | Add 21.27% | 91,800 | $54.48 |
| Q2 2023 | +15,600 | Add 25.96% | 75,700 | $0.07 |
| Q1 2023 | +7,700 | Add 14.69% | 60,100 | $0.05 |
| Q4 2022 | -500 | Reduce 0.95% | 52,400 | $0.05 |
| Q3 2022 | -4,100 | Reduce 7.19% | 52,900 | $50.68 |
| Q2 2022 | -3,300 | Reduce 5.47% | 57,000 | $45.54 |
| Q1 2022 | -6,000 | Reduce 9.05% | 60,300 | $46.47 |
| Q4 2021 | -37,200 | Reduce 35.94% | 66,300 | $50.23 |
| Q3 2021 | +57,261 | Add 123.84% | 103,500 | $53.09 |
| Q2 2021 | -17,261 | Reduce 27.18% | 46,239 | $61.03 |
| Q1 2021 | -26,100 | Reduce 29.13% | 63,500 | $48.79 |
| Q4 2020 | +89,600 | New Buy | 89,600 | $40.50 |
| Q3 2020 | -29,800 | Sold Out | 0 | $0.00 |
| Q2 2020 | -14,000 | Reduce 31.96% | 29,800 | $26.41 |
| Q1 2020 | -22,800 | Reduce 34.23% | 43,800 | $24.91 |
| Q4 2019 | +500 | Add 0.76% | 66,600 | $35.95 |
| Q3 2019 | +2,500 | Add 3.93% | 66,100 | $34.18 |
| Q2 2019 | +63,600 | New Buy | 63,600 | $27.99 |
| Q1 2019 | -10,193 | Sold Out | 0 | $0.00 |
| Q4 2018 | -15,207 | Reduce 59.87% | 10,193 | $23.64 |
| Q3 2018 | -37,500 | Reduce 59.62% | 25,400 | $38.74 |
| Q2 2018 | -44,400 | Reduce 41.38% | 62,900 | $33.48 |
| Q1 2018 | -49,700 | Reduce 31.66% | 107,300 | $36.23 |
| Q4 2017 | -95,600 | Reduce 37.85% | 157,000 | $31.84 |
| Q3 2017 | -62,000 | Reduce 19.71% | 252,600 | $37.42 |
| Q2 2017 | +131,300 | Add 71.63% | 314,600 | $31.22 |
| Q1 2017 | +64,200 | Add 53.90% | 183,300 | $24.63 |
| Q4 2016 | -64,400 | Reduce 35.10% | 119,100 | $25.34 |
| Q3 2016 | +84,200 | Add 84.79% | 183,500 | $19.84 |
| Q2 2016 | -25,300 | Reduce 20.30% | 99,300 | $14.27 |
| Q1 2016 | +800 | Add 0.65% | 124,600 | $15.52 |
| Q4 2015 | +6,900 | Add 5.90% | 123,800 | $17.25 |
| Q3 2015 | +41,300 | Add 54.63% | 116,900 | $12.19 |
| Q2 2015 | +23,000 | Add 43.73% | 75,600 | $12.06 |
| Q1 2015 | +9,537 | Add 22.15% | 52,600 | $8.38 |
| Q4 2014 | +15,663 | Add 57.16% | 43,063 | $7.64 |
| Q3 2014 | +7,138 | Add 35.23% | 27,400 | $6.90 |
| Q2 2014 | +6,984 | Add 52.60% | 20,262 | $8.29 |
| Q1 2014 | +13,278 | New Buy | 13,278 | $8.06 |
Renaissance Technologies's LeMaitre Vascular Investment FAQs
Renaissance Technologies first purchased LeMaitre Vascular, Inc. (LMAT) in Q1 2014, acquiring 13,278 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held LeMaitre Vascular, Inc. (LMAT) for 48 quarters since Q1 2014.
Renaissance Technologies's largest addition to LeMaitre Vascular, Inc. (LMAT) was in Q2 2017, adding 314,600 shares worth $9.82 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 180,502 shares of LeMaitre Vascular, Inc. (LMAT), valued at approximately $14.64 M.
As of the Q4 2025 filing, LeMaitre Vascular, Inc. (LMAT) represents approximately 0.02% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in LeMaitre Vascular, Inc. (LMAT) was 314,600 shares, as reported at the end of Q2 2017.